Kubo, Satoshi http://orcid.org/0000-0001-9693-9263
Miyazaki, Yusuke
Todoroki, Yasuyuki
Nagayasu, Atsushi
Kanda, Ryuichiro
Aritomi, Takafumi
Matsunaga, Satsuki
Ueno, Masanobu
Miyagawa, Ippei
Sonomoto, Koshiro
Hanami, Kentaro
Nakayamada, Shingo
Tanaka, Yoshiya http://orcid.org/0000-0002-0807-7139
Funding for this research was provided by:
Japan Society for the Promotion of Science, KAKENHI (19K17919)
Article History
Received: 17 August 2023
Accepted: 22 September 2023
First Online: 19 October 2023
Declarations
:
: Satoshi Kubo has received speaking fees from Eli Lilly, Bristol-Myers, GlaxoSmithKline, Abbvie, and also research grants from Daiichi-Sankyo, Abbvie, Boehringer Ingelheim, and Astellas. Yusuke Miyazaki has received consulting fees from AstraZeneca, speaking fees, and/or honoraria from Eli Lilly and GlaxoSmithKline. Shingo Nakayamada has received speaking fees from Bristol-Myers, UCB, Astellas, Abbvie, Eisai, Pfizer, and Takeda, and also research grants from Mitsubishi-Tanabe, Novartis, and MSD. Yoshiya Tanaka has received consulting fees, speaking fees, and/or honoraria from Abbvie, Daiichi-Sankyo, Chugai, Takeda, Mitsubishi-Tanabe, Bristol-Myers, Astellas, Eisai, Janssen, Pfizer, Asahi-Kasei, Eli Lilly, GlaxoSmithKline, UCB, Teijin, MSD, and Santen, and also research grants from Mitsubishi-Tanabe, Takeda, Chugai, Astellas, Eisai, Taisho-Toyama, Kyowa-Kirin, Abbvie, and Bristol-Myers. Yasuyuki Todoroki, Atsushi Nagayasu, Ryuichiro Kanda, Takafumi Aritomi, Satsuki Matsunaga, Masanobu Ueno, Ippei Miyagawa, Koshiro Sonomoto, and Kentaro Hanami have nothing to declare.
: This study was approved by the ethics review board of the University of Occupational and Environmental Health, Japan (UOEHCRB21-068). This study was carried out in compliance with the Helsinki Declaration. Informed consent was obtained from patients while utilizing anonymized data.